Trial intelligence / Profile preview

Weekly Paclitaxel Plus Carboplatin in Preoperative Breast Cancer

NCT01203267Phase 2Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Dec 2007
Primary completion
Dec 2008
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, carboplatin in breast cancer, sponsored by Shanghai Jiao Tong University School of Medicine. Started Dec 2007; status: completed.

02

Drugs

paclitaxelcarboplatin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01203267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01203267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call